Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
EMBO Molecular Medicine|June 25, 2020
Innovations, challenges, and minimal information for standardization of humanized miceRenata Stripecke, Christian Münz, Jan Jacob Schuringa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2016
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid TumorsMarina Bacac, Tanja Fauti, Johannes Sam, et al.
Cancer Research|May 16, 2020
The PET-Tracer 89Zr-Df-IAB22M2C Enables Monitoring of Intratumoral CD8 T-cell Infiltrates in Tumor-Bearing Humanized Mice after T-cell Bispecific Antibody TreatmentChristoph M Griessinger, Tove Olafsen, Alessandro Mascioni, et al.
Mabs|May 11, 2021
Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapyInja Waldhauer, Valeria Gonzalez-Nicolini, Anne Freimoser-Grundschober, et al.
Nature Cancer|March 1, 2021
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunityIsabelle Solomon, Maria Amann, Anne Goubier, et al.
Nature|September 28, 2022
PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cellsLaura Codarri Deak, Valeria Nicolini, Masao Hashimoto, et al.
Molecular Cancer Therapeutics|August 2, 2022
A Novel EGFRvIII T-Cell Bispecific Antibody for the Treatment of GlioblastomaRaffaella Iurlaro, Inja Waldhauer, Ester Planas-Rigol, et al.
Science Translational Medicine|October 5, 2018
p95HER2-T cell bispecific antibody for breast cancer treatmentIrene Rius Ruiz, Rocio Vicario, Beatriz Morancho, et al.
Elife|August 11, 2021
Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodiesS Jordan Kerns, Chaitra Belgur, Debora Petropolis, et al.
Blood|March 4, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapyJohannes Sam, Thomas Hofer, Christine Kuettel, et al.
Pageof 7